Stockreport

BRIEF-Trovagene Completes First Dosing Cohort Of Patients In Phase 1B/2 Trial Of PCM-075 [Reuters]

TROVAGENE  (TROV) 
Last trovagene earnings: 3/6 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: trovagene.com
PDF BRIEF-Trovagene Completes First Dosing Cohort Of Patients In Phase 1B/2 Trial Of PCM-075 | Reuters Reuters Staff 1 Min Read May 17 (Reuters) - Trovagene Inc: * TROVAGENE [Read more]